Private Equity
Paris-based AblaCare, a medical device firm focused on women's health and fertility care, has secured 10 million euros in Series A funding. The investor was Sofinnova Partners.
3 min read · 09 July 2019
At the beginning of each year, Jim Orlando looks backwards and forwards on trends shaping the Canadian technology startup industry. With time on his hands prior to starting his new job at Wittington Investments, Orlando decided to revisit the multiple fearless forecasts he made for 2019 in January, including the state of Canada's startup financing environment, emerging technology trends, and trends at the international level. In a PE Hub Canada feature article, he reviews his prior thinking and awards positive grades in some areas and less positive ones in others.
4 min read · 09 July 2019
Mountain View, California-based IGM Biosciences Inc, a biotech firm focused on developing engineered IgM antibodies for therapeutic use, has raised $102 million in Series C financing. The investors included Redmile Group, Janus Henderson Investors and Vivo Capital.
1 min read · 09 July 2019
BioNTech SE, a German biotech company focused on treating cancer and other serious diseases, has raised $325 million in Series B funding. Fidelity Management & Research Company was the lead investor.
3 min read · 09 July 2019
Avestria Ventures is seeking to raise $50 million for its debut fund, according to an SEC filing. The California-based venture firm invests in early-stage women's health and life science companies.
1 min read · 09 July 2019
Maniv Mobility, an Israeli venture firm focused on mobility tech, has raised $100 million for its second fund, reported Reuters. The investors in Maniv's fund include Alliance Ventures, the strategic venture capital arm of Renault-Nissan-Mitsubishi, Aptiv, BMW i Ventures, Hyundai Motor Group, Lear Corp, LG Electronics, Shell Ventures and Valeo.
1 min read · 09 July 2019
Cambridge, Massachusetts-based GNS Healthcare, a precision medicine company, has raised $23 million in Series D funding round. Cigna Ventures led the round.
1 min read · 09 July 2019
Redwood City, California-based Revolution Medicines Inc, a developer of medicines for cancer patients, has secured $100 million in Series C financing. The investors included Boxer Capital of the Tavistock Group, Cormorant Capital, Deerfield Management, Fidelity Management & Research Company, Vivo Capital, Biotechnology Value Fund, Nextech Invest, Schroder Adveq, The Column Group, Third Rock Ventures and Casdin Capital.
1 min read · 09 July 2019
Hifi Engineering Inc, a Calgary-based provider of leak detection and incident prevention technology, has raised $10 million in financing from BDC Capital and an undisclosed strategic investor. BDC invested through Ottawa’s $700 million clean technology strategy, announced last year. Hifi's other investors include Cenovus Environmental Opportunity Fund and Enbridge Inc. Founded in 2007 by CTO John Hull, Hifi develops and supplies fibre optic sensing technology for preventative leak detection in pipelines and monitoring of critical assets. The funds raised will be used to accelerate the company's growth and support continued research and development.
3 min read · 08 July 2019
Park City, Utah-based Amp Human, a maker of products for athletes, has secured an undisclosed amount of funding. Lance Armstrong's venture firm Next Ventures was the lead investor.
1 min read · 08 July 2019
